PDCD1 and neoplasm: In this study, we compared the anti-PD-1 alone treated group with the cGAMP/anti-PD-1 combination treated group, for the purpose of revealing the effect of anti-PD-1 treatment on tumor glycolysis in a highly immune-activated tumor.